Comparison of human chorionic gonadotropin and gonadotropin-releasing hormone agonist for final oocyte maturation in oocyte donor cycles

被引：32
|
作者：
Shapiro, Bruce S.
Daneshmand, Said T.
Garner, Forest C.
Aguirre, Martha
Ross, Richard
机构：
[1] Fertil Ctr Las Vegas, Las Vegas, NV 89117 USA
[2] Univ Nevada, Sch Med, Dept Obstet & Gynecol, Las Vegas, NV 89154 USA
来源：
FERTILITY AND STERILITY | 2007年 / 88卷 / 01期
关键词：
D O I：
10.1016/j.fertnstert.2006.11.069
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
In this retrospective study of 74 oocyte-donor IVF cycles, the rates of fertilization, implantation, clinical pregnancy, ongoing pregnancy, and early pregnancy loss were similar after an agonist or hCG trigger. These findings suggest that the agonist trigger is a viable alternative for oocyte donors with significant risk factors for ovarian hyperstimulation syndrome.
引用
收藏
页码：237 / 239
页数：3
相关论文
共 50 条
  • [41] Maternal and neonatal outcomes after gonadotropin-releasing hormone agonist trigger for final oocyte maturation in patients undergoing in vitro fertilization
    Budinetz, Tara H.
    Mann, Jessica S.
    Griffin, Daniel W.
    Benadiva, Claudio A.
    Nulsen, John C.
    Engmann, Lawrence L.
    FERTILITY AND STERILITY, 2014, 102 (03) : 753 - 758
  • [42] Use of a gonadotropin-releasing hormone agonist or human chorionic gonadotropin for timed insemination in cattle
    Schmitt, EJP
    Diaz, T
    Drost, M
    Thatcher, WW
    JOURNAL OF ANIMAL SCIENCE, 1996, 74 (05) : 1084 - 1091
  • [43] Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles
    Youssef, Mohamed A. F. M.
    Van der Veen, Fulco
    Al-Inany, Hesham G.
    Griesinger, Georg
    Mochtar, Monique H.
    Aboulfoutouh, Ismail
    Khattab, Sherif M.
    van Wely, Madelon
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2011, (01):
  • [44] Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response
    Chang, Frank E.
    Beall, Stephanie A.
    Cox, Jeris M.
    Richter, Kevin S.
    DeCherney, Alan H.
    Levy, Michael J.
    FERTILITY AND STERILITY, 2016, 106 (05) : 1093 - +
  • [45] Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles
    Youssef, Mohamed A. F. M.
    Van der Veen, Fulco
    Al-Inany, Hesham G.
    Griesinger, Georg
    Mochtar, Monique H.
    van Wely, Madelon
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (11):
  • [46] Use of dual trigger with gonadotropin-releasing hormone agonist (GnRH-a) and human chorionic gonadotropin (hCG) to optimize oocyte recovery rates and IVF results
    Inarra, M. J.
    Crisol, L.
    Guembe, M. A.
    HUMAN REPRODUCTION, 2015, 30 : 409 - 409
  • [47] The Quality of the Oocyte Cohort is Affected by the Magnitude of the Luteal Hormone Surge After the Use of Gonadotropin-Releasing Hormone Agonist to "Trigger" Oocyte Maturation.
    Shapiro, B. S.
    Daneshmand, S. T.
    Restrepod, H.
    Garner, F. C.
    Aguirre, M.
    Hudson, C.
    FERTILITY AND STERILITY, 2010, 93 (05) : S6 - S6
  • [48] Reproductive outcomes after a single dose of gonadotropin-releasing hormone agonist compared with human chorionic gonadotropin for the induction of final oocyte maturation in hyper-responder women aged 35-40 years
    Tannus, Samer
    Turki, Rola
    Cohen, Yoni
    Son, Weon-Young
    Shavit, Tal
    Dahan, Michael Haim
    FERTILITY AND STERILITY, 2017, 107 (06) : 1323 - +
  • [49] Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all'' strategy: a prospective multicentric study
    Griesinger, Georg
    Schultz, Laura
    Bauer, Thomas
    Broessner, Anke
    Frambach, Thorsten
    Kissler, Stefan
    FERTILITY AND STERILITY, 2011, 95 (06) : 2029 - U195
  • [50] DUAL TRIGGER WITH GONADOTROPIN RELEASING HORMONE AGONIST (GnRHa) AND HUMAN CHORIONIC GONADOTROPIN (HCG) FOR THE TREATMENT OF 'IMMATURE OOCYTE SYNDROME' (IOS)
    Griffin, D.
    Engmann, L.
    Budinetz, T.
    Kummer, N.
    Nulsen, J.
    Benadiva, C.
    FERTILITY AND STERILITY, 2012, 98 (03) : S156 - S156
12345